Vivera Pharmaceuticals
PrivateLast Round
Strategic
Nov 25, 2020
Total Funding Raised
$440M
Company Overview
Vivera Pharmaceuticals is a biopharmaceutical and medical technology company that develops drug delivery systems, medical devices, and therapeutics for pain management and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Telemedicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivera Pharmaceuticals Comparables
Compare Vivera Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biora Therapeutics | 58% |
Vivera Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 25, 2020 | ||||
| Private Placement | Jun 1, 2020 |
Vivera Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JR Dallas Wealth Management | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 50% MoM, from 1.3K to 2K.
- Apr 15, 2026
Monthly visitors grew 158% MoM, reaching 1.3K.
Vivera Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vivera Pharmaceuticals's valuation, stock price, and market status.
Is Vivera Pharmaceuticals a public or private company?
Vivera Pharmaceuticals is a private company.
What is the current stock price of Vivera Pharmaceuticals?
Vivera Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Vivera Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivera Pharmaceuticals worth (valuation)?
Valuation information for Vivera Pharmaceuticals is not publicly available.
Can I buy Vivera Pharmaceuticals stock?
Vivera Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivera Pharmaceuticals's last funding round?
Vivera Pharmaceuticals's most recent funding round was Strategic on November 25, 2020.
Who are the main investors in Vivera Pharmaceuticals?
Key investors in Vivera Pharmaceuticals include JR Dallas Wealth Management.
Will Vivera Pharmaceuticals IPO soon?
No public IPO plans have been announced for Vivera Pharmaceuticals.
How can I track Vivera Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Vivera Pharmaceuticals's shares on secondary markets.